These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 1817672)
21. Synthesis and ACE inhibitory activity of the stereoisomers of perindopril (S 9490) and perindoprilate (S 9780). Vincent M; Marchand B; Rémond G; Jaguelin-Guinamant S; Damien G; Portevin B; Baumal JY; Volland JP; Bouchet JP; Lambert PH Drug Des Discov; 1992; 9(1):11-28. PubMed ID: 1457697 [TBL] [Abstract][Full Text] [Related]
22. [Symposium on future prospects of angiotensin converting enzyme. Presentation of perindopril, a new and potent ACE inhibitor. Perindopril exerts an efficacious and rapid inhibition of ACE in plasma as well as in tissues]. Med Clin (Barc); 1991 Apr; 96(16):suppl 2 p.. PubMed ID: 2051826 [No Abstract] [Full Text] [Related]
23. Acute and chronic effects of perindopril on tissue angiotensin converting enzyme activity. Mendelsohn FA; Pupic V; Jackson B; Cubela R; Johnston CI Am J Hypertens; 1991 Mar; 4(3 Pt 2):220S-225S. PubMed ID: 1645981 [TBL] [Abstract][Full Text] [Related]
24. Gas chromatography-mass spectrometry of perindopril and its active free metabolite, an angiotensin convertase inhibitor: choice of derivatives and ionization modes. Tsaconas C; Devissaguet M; Padieu P J Chromatogr; 1989 Mar; 488(1):249-65. PubMed ID: 2715284 [TBL] [Abstract][Full Text] [Related]
25. Antihypertensive effect of perindopril: experimental pharmacology. Barthelmebs M; Devissaguet M; Imbs JL Clin Exp Hypertens A; 1989; 11 Suppl 2():471-86. PubMed ID: 2691126 [TBL] [Abstract][Full Text] [Related]
26. Development and validation of a capillary electrophoresis method with laser-induced fluorescence detection for the determination of captopril in human urine and pharmaceutical preparations. Pérez-Ruiz T; Martínez-Lozano C; Galera R Electrophoresis; 2006 Jun; 27(12):2310-6. PubMed ID: 16718646 [TBL] [Abstract][Full Text] [Related]
27. Radioimmunoassay of guanabenz, an antihypertensive agent. Ohata K; Yokoyama N; Sakamoto H; Kohno S; Kobayashi M; Murai K; Kashima K; Tatsumi H Arzneimittelforschung; 1984; 34(12):1704-8. PubMed ID: 6543306 [TBL] [Abstract][Full Text] [Related]
28. The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patients. Lees KR; Reid JL Eur J Clin Pharmacol; 1987; 31(5):519-24. PubMed ID: 3030762 [TBL] [Abstract][Full Text] [Related]
29. Development of a radioimmunoassay for the determination of buprenorphine in biological samples. Debrabandere L; Van Boven M; Daenens P Analyst; 1993 Feb; 118(2):137-43. PubMed ID: 8442513 [TBL] [Abstract][Full Text] [Related]
30. Identification and determination of selected medicines reducing hypertension by densitometric and gas chromatographic methods. Czerwińska K; Wyszomirska E; Kaniewska T Acta Pol Pharm; 2001; 58(5):331-8. PubMed ID: 11876439 [TBL] [Abstract][Full Text] [Related]
31. A radioimmunoassay for MC-838 (altiopril calcium), a novel angiotensin-converting enzyme inhibitor. Hinohara Y; Tanaka S; Wakabayashi K J Pharmacobiodyn; 1988 Jun; 11(6):411-5. PubMed ID: 3171883 [TBL] [Abstract][Full Text] [Related]
32. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease. Zhuo JL; Froomes P; Casley D; Liu JJ; Murone C; Chai SY; Buxton B; Mendelsohn FA Circulation; 1997 Jul; 96(1):174-82. PubMed ID: 9236432 [TBL] [Abstract][Full Text] [Related]
33. Hydrophilic interaction liquid chromatography/positive ion electrospray ionization mass spectrometry method for the quantification of perindopril and its main metabolite in human plasma. Georgakakou S; Kazanis M; Panderi I Anal Bioanal Chem; 2010 Jul; 397(6):2161-70. PubMed ID: 20195579 [TBL] [Abstract][Full Text] [Related]
34. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels. Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017 [TBL] [Abstract][Full Text] [Related]
35. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition. Tokita Y; Franco-Saenz R; Mulrow PJ Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of perindopril and its metabolites in healthy volunteers. Devissaguet JP; Ammoury N; Devissaguet M; Perret L Fundam Clin Pharmacol; 1990; 4(2):175-89. PubMed ID: 2351367 [TBL] [Abstract][Full Text] [Related]
37. ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients. Fogari R; Zoppi A; Lazzari P; Preti P; Mugellini A; Corradi L; Lusardi P J Cardiovasc Pharmacol; 1998 Oct; 32(4):616-20. PubMed ID: 9781930 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of tissue angiotensin converting enzyme by perindopril: in vivo assessment in the rat using radioinhibitor binding displacement. Jackson B; Cubela RB; Johnston CI J Pharmacol Exp Ther; 1988 Jun; 245(3):950-5. PubMed ID: 2838609 [TBL] [Abstract][Full Text] [Related]
39. Acute and chronic in vivo inhibition of angiotensin-converting enzyme by perindopril in the endothelium and adventitia of large arteries and organs of the rabbit. Zhuo J; Casley D; Murone C; Mendelsohn FA J Cardiovasc Pharmacol; 1997 Mar; 29(3):297-310. PubMed ID: 9125666 [TBL] [Abstract][Full Text] [Related]
40. Determination of a new angiotensin converting enzyme inhibitor and its active metabolite in plasma and urine by gas chromatography-mass spectrometry. Kaiser G; Ackermann R; Dieterle W; Dubois JP J Chromatogr; 1987 Aug; 419():123-33. PubMed ID: 3667772 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]